Ophthalmologic emergency — sudden IOP elevation from blocked aqueous outflow; vision loss if not treated within hours.
Also known as: acute angle-closure glaucoma, AACG, angle closure crisis, pupillary block glaucoma
Overview
Sudden, marked rise in intraocular pressure (IOP) caused by mechanical obstruction of aqueous humor outflow at the trabecular meshwork from apposition of the iris against the angle. Most often results from pupillary block in an anatomically predisposed eye with a shallow anterior chamber.
Epidemiology
Incidence ~1 per 1,000 per year over age 40 in susceptible populations. Higher prevalence in Asians (especially East Asians) and Inuit; female:male approximately 3:1; mean age 55-65. Hyperopes have shallower anterior chambers and higher risk.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Acute Angle-Closure Glaucoma outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Dim light (movie theater, evening) — pupil mid-dilated, maximizes iris-lens contact and iris bunching at angle
Pathophysiology
Pupillary block: in eyes with shallow anterior chamber and crowded angle, the iris contacts the anterior lens surface, blocking aqueous flow from posterior to anterior chamber. Aqueous accumulates posteriorly, bowing the iris forward (iris bombe) and pressing the peripheral iris against the trabecular meshwork. IOP rapidly rises (often >40-60 mmHg), causing optic nerve ischemia, corneal edema, and pain. Plateau iris (less common): anterior insertion of the ciliary body causes peripheral iris to crowd the angle without pupillary block.
Clinical presentation
Symptoms
Sudden severe unilateral eye pain and headache
Blurred vision and halos around lights (corneal edema)
Nausea and vomiting (vagal response) — often misdiagnosed as abdominal/GI process
Photophobia
Symptoms may follow dim-light exposure, anticholinergic use, or emotional stress
Signs / physical exam
Markedly elevated IOP — typically 40-80 mmHg (normal 10-21)
Systemic carbonic anhydrase inhibitor — acetazolamide 500 mg IV or PO (avoid in sulfa allergy with caution, sickle cell)
Topical pilocarpine 1-2% every 15 min × 2 doses once IOP is reduced below 40 mmHg (pilocarpine is ineffective at very high IOP because iris sphincter is ischemic)
Hyperosmotic agent — oral glycerol 1-2 g/kg or IV mannitol 1-2 g/kg — if IOP not responding (avoid in heart failure)
Topical corticosteroid (prednisolone acetate 1%) every 15-30 min to reduce inflammation
Second-line / adjunct
DEFINITIVE — laser peripheral iridotomy (LPI) by ophthalmology once cornea clears, usually within 24-48 hours; LPI also performed on fellow eye prophylactically (high risk)
Cataract extraction (lens-induced) increasingly favored as definitive therapy in many cases
Surgical iridectomy if LPI not feasible
Trabeculectomy or tube shunt if chronic angle closure with persistent IOP elevation
Argon laser peripheral iridoplasty in plateau iris configuration
Complications
Permanent optic nerve damage and visual field loss within hours
Central retinal artery or vein occlusion from sustained high IOP
Glaukomflecken (anterior subcapsular lens opacities from ischemia)
Iris atrophy with sphincter paralysis (fixed dilated pupil)
Chronic angle-closure glaucoma with peripheral anterior synechiae
Bilateral disease — fellow eye is at high risk; prophylactic LPI is standard
PANCE pearls
Acute angle-closure glaucoma can present with nausea and headache and be misdiagnosed as GI illness or migraine — always check the eye and the pupil.
Pilocarpine does not work when IOP is very high because the ischemic iris sphincter cannot constrict — lower IOP first with aqueous suppressants and hyperosmotics, then give pilocarpine.
Topiramate and sulfa-derivative drugs can cause idiosyncratic bilateral angle closure from ciliary body swelling — stop the drug and treat medically; iridotomy is NOT effective in this mechanism.
After medical control, definitive treatment is laser peripheral iridotomy (or lens extraction) — and the fellow eye almost always needs prophylactic iridotomy.
References
AAO 2020 — American Academy of Ophthalmology. Primary Angle Closure Disease Preferred Practice Pattern. Ophthalmology 2021;128(1):P30-P70
EAGLE Trial — Azuara-Blanco A et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet 2016;388(10052):1389-1397
ZAP Trial — He M et al. Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial. Lancet 2019;393(10181):1609-1618
Practice EENT questions on FirstPassPA
Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.